Latest filing published 16 Sept 2020 for Mersana Therapeutics, Inc., €45k.
Filing timeline
BuySaleInsider track record
Eva M. Jack: trading record in brief
Eva M. Jack discloses dealings in Mersana Therapeutics, Inc. to SEC (Form 4). Altogether 2 filings, all relating to 14 September 2020.
Every open-market trade on record is a sale: 1 sale worth €653k. Besides market trades, the filings include 1 option exercise.
The record was last updated on 16 September 2020 with an option exercise (€45k) in Mersana Therapeutics, Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Eva M. Jack
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,248 shares@ US$1.536.5% of flowCommon StockSEC:0001104659-20-105768:0
- 35,248 shares@ US$22.0093.5% of flowCommon StockSEC:0001104659-20-105768:1
2 of 2 declarations
